Cargando…
Adoptive immunotherapy with engineered T cells expressing and HLA-A2 restricted affinity-enhanced TCR for LAGE-1 and NY-ESO-1 in patients with multiple myeloma following auto-SCT
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990335/ http://dx.doi.org/10.1186/2051-1426-1-S1-P30 |
| _version_ | 1782312262544916480 |
|---|---|
| author | Rapoport, Aaron P Stadtmauer, Edward A Vogl, Dan T Weiss, Brendan Binder-Scholl, Gwendolyn K Smethurst, Dominic P Finklestein, Jeffrey Kulikovskaya, Irina Gupta, Minnal Brewer, Joanna E Bennett, Alan D Gerry, Andrew B Pumphrey, Nick J Tayton-Martin, Helen K Ribeiro, Lilliam Badros, Ashraf Z Yanovich, Saul Akpek, Gorgun Kerr, Naseem Philip, Sunita Westphal, Sandra Bruce, Levine L Jakobsen, Bent K June, Carl H Kalos, Michael |
| author_facet | Rapoport, Aaron P Stadtmauer, Edward A Vogl, Dan T Weiss, Brendan Binder-Scholl, Gwendolyn K Smethurst, Dominic P Finklestein, Jeffrey Kulikovskaya, Irina Gupta, Minnal Brewer, Joanna E Bennett, Alan D Gerry, Andrew B Pumphrey, Nick J Tayton-Martin, Helen K Ribeiro, Lilliam Badros, Ashraf Z Yanovich, Saul Akpek, Gorgun Kerr, Naseem Philip, Sunita Westphal, Sandra Bruce, Levine L Jakobsen, Bent K June, Carl H Kalos, Michael |
| author_sort | Rapoport, Aaron P |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3990335 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-39903352014-05-01 Adoptive immunotherapy with engineered T cells expressing and HLA-A2 restricted affinity-enhanced TCR for LAGE-1 and NY-ESO-1 in patients with multiple myeloma following auto-SCT Rapoport, Aaron P Stadtmauer, Edward A Vogl, Dan T Weiss, Brendan Binder-Scholl, Gwendolyn K Smethurst, Dominic P Finklestein, Jeffrey Kulikovskaya, Irina Gupta, Minnal Brewer, Joanna E Bennett, Alan D Gerry, Andrew B Pumphrey, Nick J Tayton-Martin, Helen K Ribeiro, Lilliam Badros, Ashraf Z Yanovich, Saul Akpek, Gorgun Kerr, Naseem Philip, Sunita Westphal, Sandra Bruce, Levine L Jakobsen, Bent K June, Carl H Kalos, Michael J Immunother Cancer Poster Presentation BioMed Central 2013-11-07 /pmc/articles/PMC3990335/ http://dx.doi.org/10.1186/2051-1426-1-S1-P30 Text en Copyright © 2013 Rapoport et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Poster Presentation Rapoport, Aaron P Stadtmauer, Edward A Vogl, Dan T Weiss, Brendan Binder-Scholl, Gwendolyn K Smethurst, Dominic P Finklestein, Jeffrey Kulikovskaya, Irina Gupta, Minnal Brewer, Joanna E Bennett, Alan D Gerry, Andrew B Pumphrey, Nick J Tayton-Martin, Helen K Ribeiro, Lilliam Badros, Ashraf Z Yanovich, Saul Akpek, Gorgun Kerr, Naseem Philip, Sunita Westphal, Sandra Bruce, Levine L Jakobsen, Bent K June, Carl H Kalos, Michael Adoptive immunotherapy with engineered T cells expressing and HLA-A2 restricted affinity-enhanced TCR for LAGE-1 and NY-ESO-1 in patients with multiple myeloma following auto-SCT |
| title | Adoptive immunotherapy with engineered T cells expressing and HLA-A2 restricted affinity-enhanced TCR for LAGE-1 and NY-ESO-1 in patients with multiple myeloma following auto-SCT |
| title_full | Adoptive immunotherapy with engineered T cells expressing and HLA-A2 restricted affinity-enhanced TCR for LAGE-1 and NY-ESO-1 in patients with multiple myeloma following auto-SCT |
| title_fullStr | Adoptive immunotherapy with engineered T cells expressing and HLA-A2 restricted affinity-enhanced TCR for LAGE-1 and NY-ESO-1 in patients with multiple myeloma following auto-SCT |
| title_full_unstemmed | Adoptive immunotherapy with engineered T cells expressing and HLA-A2 restricted affinity-enhanced TCR for LAGE-1 and NY-ESO-1 in patients with multiple myeloma following auto-SCT |
| title_short | Adoptive immunotherapy with engineered T cells expressing and HLA-A2 restricted affinity-enhanced TCR for LAGE-1 and NY-ESO-1 in patients with multiple myeloma following auto-SCT |
| title_sort | adoptive immunotherapy with engineered t cells expressing and hla-a2 restricted affinity-enhanced tcr for lage-1 and ny-eso-1 in patients with multiple myeloma following auto-sct |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990335/ http://dx.doi.org/10.1186/2051-1426-1-S1-P30 |
| work_keys_str_mv | AT rapoportaaronp adoptiveimmunotherapywithengineeredtcellsexpressingandhlaa2restrictedaffinityenhancedtcrforlage1andnyeso1inpatientswithmultiplemyelomafollowingautosct AT stadtmaueredwarda adoptiveimmunotherapywithengineeredtcellsexpressingandhlaa2restrictedaffinityenhancedtcrforlage1andnyeso1inpatientswithmultiplemyelomafollowingautosct AT vogldant adoptiveimmunotherapywithengineeredtcellsexpressingandhlaa2restrictedaffinityenhancedtcrforlage1andnyeso1inpatientswithmultiplemyelomafollowingautosct AT weissbrendan adoptiveimmunotherapywithengineeredtcellsexpressingandhlaa2restrictedaffinityenhancedtcrforlage1andnyeso1inpatientswithmultiplemyelomafollowingautosct AT binderschollgwendolynk adoptiveimmunotherapywithengineeredtcellsexpressingandhlaa2restrictedaffinityenhancedtcrforlage1andnyeso1inpatientswithmultiplemyelomafollowingautosct AT smethurstdominicp adoptiveimmunotherapywithengineeredtcellsexpressingandhlaa2restrictedaffinityenhancedtcrforlage1andnyeso1inpatientswithmultiplemyelomafollowingautosct AT finklesteinjeffrey adoptiveimmunotherapywithengineeredtcellsexpressingandhlaa2restrictedaffinityenhancedtcrforlage1andnyeso1inpatientswithmultiplemyelomafollowingautosct AT kulikovskayairina adoptiveimmunotherapywithengineeredtcellsexpressingandhlaa2restrictedaffinityenhancedtcrforlage1andnyeso1inpatientswithmultiplemyelomafollowingautosct AT guptaminnal adoptiveimmunotherapywithengineeredtcellsexpressingandhlaa2restrictedaffinityenhancedtcrforlage1andnyeso1inpatientswithmultiplemyelomafollowingautosct AT brewerjoannae adoptiveimmunotherapywithengineeredtcellsexpressingandhlaa2restrictedaffinityenhancedtcrforlage1andnyeso1inpatientswithmultiplemyelomafollowingautosct AT bennettaland adoptiveimmunotherapywithengineeredtcellsexpressingandhlaa2restrictedaffinityenhancedtcrforlage1andnyeso1inpatientswithmultiplemyelomafollowingautosct AT gerryandrewb adoptiveimmunotherapywithengineeredtcellsexpressingandhlaa2restrictedaffinityenhancedtcrforlage1andnyeso1inpatientswithmultiplemyelomafollowingautosct AT pumphreynickj adoptiveimmunotherapywithengineeredtcellsexpressingandhlaa2restrictedaffinityenhancedtcrforlage1andnyeso1inpatientswithmultiplemyelomafollowingautosct AT taytonmartinhelenk adoptiveimmunotherapywithengineeredtcellsexpressingandhlaa2restrictedaffinityenhancedtcrforlage1andnyeso1inpatientswithmultiplemyelomafollowingautosct AT ribeirolilliam adoptiveimmunotherapywithengineeredtcellsexpressingandhlaa2restrictedaffinityenhancedtcrforlage1andnyeso1inpatientswithmultiplemyelomafollowingautosct AT badrosashrafz adoptiveimmunotherapywithengineeredtcellsexpressingandhlaa2restrictedaffinityenhancedtcrforlage1andnyeso1inpatientswithmultiplemyelomafollowingautosct AT yanovichsaul adoptiveimmunotherapywithengineeredtcellsexpressingandhlaa2restrictedaffinityenhancedtcrforlage1andnyeso1inpatientswithmultiplemyelomafollowingautosct AT akpekgorgun adoptiveimmunotherapywithengineeredtcellsexpressingandhlaa2restrictedaffinityenhancedtcrforlage1andnyeso1inpatientswithmultiplemyelomafollowingautosct AT kerrnaseem adoptiveimmunotherapywithengineeredtcellsexpressingandhlaa2restrictedaffinityenhancedtcrforlage1andnyeso1inpatientswithmultiplemyelomafollowingautosct AT philipsunita adoptiveimmunotherapywithengineeredtcellsexpressingandhlaa2restrictedaffinityenhancedtcrforlage1andnyeso1inpatientswithmultiplemyelomafollowingautosct AT westphalsandra adoptiveimmunotherapywithengineeredtcellsexpressingandhlaa2restrictedaffinityenhancedtcrforlage1andnyeso1inpatientswithmultiplemyelomafollowingautosct AT brucelevinel adoptiveimmunotherapywithengineeredtcellsexpressingandhlaa2restrictedaffinityenhancedtcrforlage1andnyeso1inpatientswithmultiplemyelomafollowingautosct AT jakobsenbentk adoptiveimmunotherapywithengineeredtcellsexpressingandhlaa2restrictedaffinityenhancedtcrforlage1andnyeso1inpatientswithmultiplemyelomafollowingautosct AT junecarlh adoptiveimmunotherapywithengineeredtcellsexpressingandhlaa2restrictedaffinityenhancedtcrforlage1andnyeso1inpatientswithmultiplemyelomafollowingautosct AT kalosmichael adoptiveimmunotherapywithengineeredtcellsexpressingandhlaa2restrictedaffinityenhancedtcrforlage1andnyeso1inpatientswithmultiplemyelomafollowingautosct |